Abbreviated new drug application filings have declined to 600 in the financial year 2025 (ending in September) versus 740 in ...

Granules India arm gets USFDA tentative nod for generic ADHD tablets with 180-day exclusivity eligibility, expanding its ...

Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health ...

Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, on Thursday announced it has received Tentative Approval (TA) from the U.S. Food and Drug Administration (FDA) for ...

Granules India receives USFDA tentative approval for generic amphetamine extended-release tablets for ADHD treatment.

Granules gets US FDA tentative nod with 180-day exclusivity for generic amphetamine XR tablets: Our Bureau, Bengaluru Thursday, January 8, 2026, 16:15 Hrs [IST] Granules Pharmaceu ...

Granules Pharmaceuticals, a wholly-owned subsidiary of Granules India, has received tentative approval from the US Food and ...

Stocks like Tata Steel, NCL Industries, Infosys, Gland Pharma, Cipla, IRB Infrastructure Developers, Meesho, Adani Green ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher") today announced that CEO Fabio Chianelli ...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base ...